The FTC is attacking drugmakers' 'patent thickets'

The Federal Trade Commission has challenged the validity of over 100 drug product patents in an effort to increase competition and potentially lower some prices.

Related Keywords

United States ,America ,Lina Khan ,Megan Van Etten ,Joe Biden ,Office Of Policy Planning ,Glaxosmithkline ,Amneal Pharmaceuticals ,Federal Trade Commission ,Hannah Garden Monheit ,Orange Book Listed ,Orange Book ,Pharmaceutical Research ,